SCHULER JACK W

SEC source: 0001628280-20-004572 · wf-form4_158593086387560.xml · derivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,779

Underlying: Common Stock · 13,779 shares

Expires 2030-04-01

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments, with the first installment vesting on May 1, 2020.

SEC source: 0001628280-20-004519 · wf-form4_158585501828407.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 14,301,928

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.07 to $8.87, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

F3 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001628280-20-004471 · wf-form4_158577536606803.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 14,181,928

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.88 to $8.88, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

F3 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001628280-20-004404 · wf-form4_158568193734588.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 14,101,928

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.67 to $8.33, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

F3 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001628280-20-004360 · wf-form4_158559668460629.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 13,999,965

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.75 to $8.49, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

F3 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001628280-20-004269 · wf-form4_158535912664416.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 13,851,928

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.99 to $8.00, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

F3 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001628280-20-004091 · wf-form4_158525086236673.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 13,701,928

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.51 to $7.30, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

F3 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001628280-20-004257 · wf-form4a_158535733555029.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 13,701,928

F1 · kind: The Form 4 filed on March 26, 2020 inadvertently reported an incorrect amount of securities beneficially owned for the Schuler Family Foundation. The amount shown on the original Form 4 was for 977,023 shares while the correct amount should have been 2,177,023 shares. The original Form 4 also inadvertently reported an incorrect Transaction Code for the reported transaction. The Transaction Code reported on the original Form 4 was "J" while the correct Transaction Code should have been "P". All other information reported on the original Form 4 remains unchanged.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.51 to $7.30, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.

F3 · ownership.nature: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

F4 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001628280-20-004049 · wf-form4_158516462687816.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 13,551,928

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.85 to $6.00, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (4) to this Form 4.

F2 · ownership.nature: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

F3 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001628280-20-002416 · wf-form4_158283440982674.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 13,379,028

F1 · shares: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.75 to $15.63, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

F3 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001628280-20-002291 · wf-form4_158274868330915.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 13,370,028

F1 · shares: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.66 to $16.00, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

F3 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001628280-20-002184 · wf-form4a_158266206151180.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 13,360,028

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.29 to $16.33, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

F3 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001628280-20-002095 · wf-form4_158257587413568.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 13,350,028

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.00 to $16.22, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

F3 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001104659-20-019350 · tm207822d1_4.xml · nonDerivative · entry 3

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 428,396

F7 · kind: The reported securities were sold by the Jack W. Schuler Living Trust for tax purposes. On the same date, each of the Tino Hans Schuler Trust, Tanya Eva Schuler Trust, and Therese Heidi Schuler Trust (collectively, the "Trusts"), which are separate trusts established for Mr. Schuler's three children, separately acquired 10,426 shares of common stock of the Issuer (the "Schuler Children Shares"). Mr. Schuler disclaims any beneficial ownership of the Schuler Children Shares and has no pecuniary interest in any of the Schuler Children Shares. As such, transactions by the Trusts are not subject to Section 16 by Mr. Schuler.

F8 · price: This transaction was executed in multiple trades at prices ranging from $7.50 to $7.84 per share. The price reported above reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F9 · balance_after: The reported securities consist of the 394,375 shares of common stock owned by the Jack W. Schuler Living Trust, the 21 shares of common stock owned by the Renate Schuler Living Trust, and the 33,999 shares of common stock owned by the Schuler Family Foundation, in each case immediately following reported transaction.

F3 · ownership.nature: Jack W. Schuler has an indirect pecuniary interest the reported securities through (i) the Jack W. Schuler Living Trust, as its trustee and beneficiary, (ii) the Renate Schuler Living Trust, as the spouse of its trustee and beneficiary, and (iii) the Schuler Family Foundation, as its president.

SEC source: 0000905148-20-000620 · form4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 739,820

F1 · shares: These figures reflect a 1-for-5 reverse stock split effected by the Issuer on May 10, 2018.

F1 · balance_after: These figures reflect a 1-for-5 reverse stock split effected by the Issuer on May 10, 2018.

F2 · ownership.nature: The Common Stock is held directly by the Jack W. Schuler Living Trust (the "Trust"). Mr. Schuler serves as sole trustee to the Trust.

SEC source: 0001104659-20-019350 · tm207822d1_4.xml · nonDerivative · entry 2

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 471,093

F4 · kind: The reported securities were sold by the Jack W. Schuler Living Trust for tax purposes.

F5 · price: This transaction was executed in multiple trades at prices ranging from $7.655 to $7.985 per share. The price reported above reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6 · balance_after: The reported securities consist of the 437,072 shares of common stock owned by the Jack W. Schuler Living Trust, the 21 shares of common stock owned by the Renate Schuler Living Trust, and the 33,999 shares of common stock owned by the Schuler Family Foundation, in each case immediately following reported transaction.

F3 · ownership.nature: Jack W. Schuler has an indirect pecuniary interest the reported securities through (i) the Jack W. Schuler Living Trust, as its trustee and beneficiary, (ii) the Renate Schuler Living Trust, as the spouse of its trustee and beneficiary, and (iii) the Schuler Family Foundation, as its president.

SEC source: 0001104659-20-019350 · tm207822d1_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 489,496

F1 · kind: The reported securities were acquired by the Schuler Family Foundation.

F2 · balance_after: The reported securities consist of the 455,476 shares of common stock owned by the Jack W. Schuler Living Trust, the 21 shares of common stock owned by the Renate Schuler Living Trust, and the 33,999 shares of common stock owned by the Schuler Family Foundation, in each case immediately following reported transaction.

F3 · ownership.nature: Jack W. Schuler has an indirect pecuniary interest the reported securities through (i) the Jack W. Schuler Living Trust, as its trustee and beneficiary, (ii) the Renate Schuler Living Trust, as the spouse of its trustee and beneficiary, and (iii) the Schuler Family Foundation, as its president.

SEC source: 0001104659-20-008486 · tv537241_form4.xml · derivative · entry 5

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 394,375 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F14 · security: The reported derivative security was originally acquired as a component of a "Unit" by the Jack W. Schuler Living Trust on November 14, 2019.

F16 · derivative.exercise_price: The reported exercise or conversion price is subject to adjustment.

F15 · kind: The reported derivative security automatically converted into Common Stock of the issuer on January 15, 2020 following the effectiveness of the Amendment.

F11 · price: Each Unit, of which the reported derivative securities are a component, cost $1,000.

F7 · derivative.exercise_date: The Series B Convertible Preferred Stock automatically converts into 5,000 shares of Common Stock upon the effectiveness of the filing with the Secretary of State of the State of Delaware of an amendment (the "Amendment") to the Issuer's Restated Certificate of Incorporation, as amended.

F9 · derivative.expiration_date: The Series B Convertible Preferred Stock does not have an expiration date.

F10 · derivative.underlying_shares: The number of shares of Common Stock into which the reported derivative security is convertible or exercisable (or converted, as applicable) reflects the 1-for-40 reverse stock split effected by the Issuer effective January 15, 2020.

F13 · ownership.nature: Jack W. Schuler has an indirect pecuniary interest in the reported derivative securities through the Jack W. Schuler Living Trust, as its trustee and beneficiary.

SEC source: 0001104659-20-008486 · tv537241_form4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 489,946

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported securities were issued by the Issuer upon the automatic conversion on January 15, 2020 of the Series B Convertible Preferred Stock acquired by the Jack W. Schuler Living Trust on November 15, 2019 (the "Convertible Stock").

F2 · price: The Convertible Stock from which the reported securities converted was acquired as a component of a "Unit" issued by the Issuer. Each Unit was acquired by the Jack W. Schuler Living Trust at a cost of $1,000 per Unit.

F3 · balance_after: The reported securities consist of the 465,328 shares of common stock owned by the Jack W. Schuler Living Trust, the 21 shares of common stock owned by the Renate Schuler Living Trust, and the 24,597 shares of common stock owned by the Schuler Family Foundation, in each case immediately following both (i) the 1-for-40 reverse stock split effected by the Issuer on January 15, 2020 and (ii) the conversion of the Convertible Stock on January 15, 2020.

F4 · ownership.nature: Jack W. Schuler has an indirect pecuniary interest the reported securities through (i) the Jack W. Schuler Living Trust, as its trustee and beneficiary, (ii) the Renate Schuler Living Trust, as the spouse of its trustee and beneficiary, and (iii) the Schuler Family Foundation, as its president.

SEC source: 0001628280-19-014970 · wf-form4_157609623718233.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 2,177,023

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.67 to $15.75, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares of the Issuer owned by the Schuler Family Foundation (the "Foundation"). Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's common stock. As a result, this Form 4 is a voluntary report with respect to these purchases of the Issuer's common stock by the Foundation.

SEC source: 0001628280-19-014871 · wf-form4_157592763213385.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 2,172,023

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.92 to $15.97, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares of the Issuer owned by the Schuler Family Foundation (the "Foundation"). Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's common stock. As a result, this Form 4 is a voluntary report with respect to these purchases of the Issuer's common stock by the Foundation.

SEC source: 0001104659-19-065071 · tm1923120-1_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 2,167,023

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.73 to $15.77, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares of the Issuer owned by the Schuler Family Foundation (the "Foundation"). Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's common stock. As a result, this Form 4 is a voluntary report with respect to these purchases of the Issuer's common stock by the Foundation.

SEC source: 0001104659-20-008486 · tv537241_form4.xml · derivative · entry 4

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,155

Underlying: Common Stock · 394,375 shares

Expires 2027-05-19

F5 · security: The reported derivative security was acquired as a component of a "Unit" issued by the Issuer. Each Unit consisted of (i) one share of Series B Convertible Preferred Stock, par value $0.01 per share, convertible into 5,000 shares of common stock, (ii) one Series A Warrant to purchase 5,000 shares of common stock, and (iii) one Series B Warrant to purchase 5,000 shares of common stock.

F16 · derivative.exercise_price: The reported exercise or conversion price is subject to adjustment.

F6 · shares: The reported securities, which are a component of a Unit, were acquired by the Jack W. Schuler Living Trust. 3,155 Units were acquired by the Jack W. Schuler Living Trust.

F11 · price: Each Unit, of which the reported derivative securities are a component, cost $1,000.

F8 · derivative.exercise_date: The Series A Warrants and Series B Warrants are each exercisable on or after the date on which the Amendment is filed and accepted with the State of Delaware.

F10 · derivative.underlying_shares: The number of shares of Common Stock into which the reported derivative security is convertible or exercisable (or converted, as applicable) reflects the 1-for-40 reverse stock split effected by the Issuer effective January 15, 2020.

F12 · balance_after: The reported derivative security was acquired as a component of a Unit. 3,155 Units were acquired by the Jack W. Schuler Living Trust.

F13 · ownership.nature: Jack W. Schuler has an indirect pecuniary interest in the reported derivative securities through the Jack W. Schuler Living Trust, as its trustee and beneficiary.

SEC source: 0001104659-20-008486 · tv537241_form4.xml · derivative · entry 3

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,155

Underlying: Common Stock · 394,375 shares

Expires 2022-05-19

F5 · security: The reported derivative security was acquired as a component of a "Unit" issued by the Issuer. Each Unit consisted of (i) one share of Series B Convertible Preferred Stock, par value $0.01 per share, convertible into 5,000 shares of common stock, (ii) one Series A Warrant to purchase 5,000 shares of common stock, and (iii) one Series B Warrant to purchase 5,000 shares of common stock.

F16 · derivative.exercise_price: The reported exercise or conversion price is subject to adjustment.

F6 · shares: The reported securities, which are a component of a Unit, were acquired by the Jack W. Schuler Living Trust. 3,155 Units were acquired by the Jack W. Schuler Living Trust.

F11 · price: Each Unit, of which the reported derivative securities are a component, cost $1,000.

F8 · derivative.exercise_date: The Series A Warrants and Series B Warrants are each exercisable on or after the date on which the Amendment is filed and accepted with the State of Delaware.

F10 · derivative.underlying_shares: The number of shares of Common Stock into which the reported derivative security is convertible or exercisable (or converted, as applicable) reflects the 1-for-40 reverse stock split effected by the Issuer effective January 15, 2020.

F12 · balance_after: The reported derivative security was acquired as a component of a Unit. 3,155 Units were acquired by the Jack W. Schuler Living Trust.

F13 · ownership.nature: Jack W. Schuler has an indirect pecuniary interest in the reported derivative securities through the Jack W. Schuler Living Trust, as its trustee and beneficiary.

SEC source: 0001104659-20-008486 · tv537241_form4.xml · derivative · entry 2

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,155

Underlying: Common Stock · 394,375 shares

Expires not disclosed

F5 · security: The reported derivative security was acquired as a component of a "Unit" issued by the Issuer. Each Unit consisted of (i) one share of Series B Convertible Preferred Stock, par value $0.01 per share, convertible into 5,000 shares of common stock, (ii) one Series A Warrant to purchase 5,000 shares of common stock, and (iii) one Series B Warrant to purchase 5,000 shares of common stock.

F16 · derivative.exercise_price: The reported exercise or conversion price is subject to adjustment.

F6 · shares: The reported securities, which are a component of a Unit, were acquired by the Jack W. Schuler Living Trust. 3,155 Units were acquired by the Jack W. Schuler Living Trust.

F11 · price: Each Unit, of which the reported derivative securities are a component, cost $1,000.

F7 · derivative.exercise_date: The Series B Convertible Preferred Stock automatically converts into 5,000 shares of Common Stock upon the effectiveness of the filing with the Secretary of State of the State of Delaware of an amendment (the "Amendment") to the Issuer's Restated Certificate of Incorporation, as amended.

F9 · derivative.expiration_date: The Series B Convertible Preferred Stock does not have an expiration date.

F10 · derivative.underlying_shares: The number of shares of Common Stock into which the reported derivative security is convertible or exercisable (or converted, as applicable) reflects the 1-for-40 reverse stock split effected by the Issuer effective January 15, 2020.

F12 · balance_after: The reported derivative security was acquired as a component of a Unit. 3,155 Units were acquired by the Jack W. Schuler Living Trust.

F13 · ownership.nature: Jack W. Schuler has an indirect pecuniary interest in the reported derivative securities through the Jack W. Schuler Living Trust, as its trustee and beneficiary.

SEC source: 0001628280-21-013967 · wf-form4_162647031767123.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 1,267,023

F1 · ownership.nature: The reporting person disclaims beneficial ownership of the shares of Accelerate Diagnostics, Inc. (the "Issuer") owned by the Schuler Family Foundation (the "Foundation"). Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's common stock. As a result, this Form 4 is a voluntary report with respect to these purchases of the Issuer's common stock by the Foundation.

SEC source: 0001104659-19-064392 · tm1922844d1_4.xml · derivative · entry 3

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: Not disclosed

Underlying: Common Stock · 64,685 shares

Expires not disclosed

F5 · derivative.exercise_price: The initial conversion rate of 32.3428 per $1,000 principal amount of the Issuer's 2.50% Convertible Senior Notes due 2023 (the "Notes") is equivalent to an initial conversion price of approximately $30.92 per share of the Issuer's common stock. The initial conversion rate is subject to adjustment upon the occurrence of certain customary events in accordance with the terms of an indenture governing the Notes.

F6 · derivative.exercise_date: Holders of the Notes have the option to convert the Notes in multiples of $1,000 principal amount at any time prior to December 15, 2022, but only in the following circumstances: (i) if the Issuer's stock price exceeds 130% of the conversion price for 20 of the last 30 trading days of any calendar quarter after June 30, 2018; (ii) during the 5 business day period after any 5 consecutive trading day period in which the Notes' trading price is less than 98% of the product of the common stock price times the conversion rate; or (iii) the occurrence of certain corporate events, such as a change of control, merger or liquidation. At any time on or after December 15, 2022, a holder may convert its Notes in multiples of $1,000 principal amount at the option of the holder regardless of the foregoing circumstances.

F7 · derivative.expiration_date: The Notes mature on March 15, 2023, subject to earlier repurchase or conversion in accordance with their terms.

F8 · derivative.underlying_shares: Upon conversion of the Notes, the Issuer will pay or deliver, as the case may be, cash, shares of its common stock or a combination of cash and shares of its common stock, at the Issuer's election. This number represents the number of shares of common stock issuable upon conversion of the Notes being purchased by the reporting person if the Issuer elects to settle its conversion obligation solely through shares of common stock by delivering a number of shares of common stock at the initial conversion rate of 32.3428 shares of common stock per $1,000 principal amount of the Notes and cash in lieu of fractional shares of common stock.

F9 · valueOwnedAfter: Includes $30 million aggregate principal amount of the Notes purchased by the Foundation in March 2018 and an additional $10 million aggregate principal amount of the Notes purchased by the Foundation in May 2019.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares of the Issuer owned by the Schuler Family Foundation (the "Foundation"). Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's securities. As a result, this Form 4 is a voluntary report with respect to these purchases of the Issuer's securities by the Foundation.

SEC source: 0001104659-19-064392 · tm1922844d1_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 2,162,023

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.18 to $15.50, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares of the Issuer owned by the Schuler Family Foundation (the "Foundation"). Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's securities. As a result, this Form 4 is a voluntary report with respect to these purchases of the Issuer's securities by the Foundation.

SEC source: 0001104659-19-063265 · tm1922542d1_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 2,157,023

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.00 to $15.39, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares of the Issuer owned by the Schuler Family Foundation (the "Foundation"). Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's common stock. As a result, this Form 4 is a voluntary report with respect to these purchases of the Issuer's common stock by the Foundation.

SEC source: 0000899243-20-017806 · doc4.xml · nonDerivative · entry 2

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 6,217,345

F1 · shares: The shares were purchased from the underwriters in a firm-commitment underwritten public offering of shares of the Issuer's common stock that closed on October 25, 2019.

F3 · ownership.nature: The shares are held by the Jack W. Schuler Living Trust, for which the Reporting Person serves as Trustee.

SEC source: 0000899243-20-017806 · doc4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,732,800

F1 · shares: The shares were purchased from the underwriters in a firm-commitment underwritten public offering of shares of the Issuer's common stock that closed on October 25, 2019.

F2 · ownership.nature: The shares are held by the Schuler Family Foundation, for which the Reporting Person serves as President.

SEC source: 0001144204-19-041132 · tv528128_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 2,147,023

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.98 to $18.00, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares of the Issuer owned by the Schuler Family Foundation (the "Foundation"). Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's common stock. As a result, this Form 4 is a voluntary report with respect to these purchases of the Issuer's common stock by the Foundation.

SEC source: 0001144204-19-040935 · tv528043_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 2,137,023

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.01 to $18.54, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares of the Issuer owned by the Schuler Family Foundation (the "Foundation"). Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's common stock. As a result, this Form 4 is a voluntary report with respect to these purchases of the Issuer's common stock by the Foundation.

SEC source: 0001144204-19-040800 · tv527883_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 2,132,023

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.00 to $18.48, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares of the Issuer owned by the Schuler Family Foundation (the "Foundation"). Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's common stock. As a result, this Form 4 is a voluntary report with respect to these purchases of the Issuer's common stock by the Foundation.

SEC source: 0001144204-19-040609 · tv527782_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 2,127,023

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.78 to $18.00, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares of the Issuer owned by the Schuler Family Foundation (the "Foundation"). Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's common stock. As a result, this Form 4 is a voluntary report with respect to these purchases of the Issuer's common stock by the Foundation.

SEC source: 0001144204-19-040385 · tv527748_form4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 2,117,023

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.99 to $18.33, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares of the Issuer owned by the Schuler Family Foundation (the "Foundation"). Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's common stock. As a result, this Form 4 is a voluntary report with respect to these purchases of the Issuer's common stock by the Foundation.

SEC source: 0001144204-19-040244 · tv527611_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 2,112,023

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.60 to $18.59, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares of the Issuer owned by the Schuler Family Foundation (the "Foundation"). Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's common stock. As a result, this Form 4 is a voluntary report with respect to these purchases of the Issuer's common stock by the Foundation.

SEC source: 0001144204-19-039987 · tv527484_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 2,107,023

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.27 to $17.67, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares of the Issuer owned by the Schuler Family Foundation (the "Foundation"). Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's common stock. As a result, this Form 4 is a voluntary report with respect to these purchases of the Issuer's common stock by the Foundation.

SEC source: 0000905148-19-000668 · form4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 22,378,242

F1 · ownership.nature: These shares of Common Stock ("Shares") are directly owned by the Jack W. Schuler Living Trust. Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

SEC source: 0001144204-19-029553 · tv522939_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 2,097,023

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.73 to $18.80, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares of the Issuer owned by the Schuler Family Foundation (the "Foundation"). Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's common stock. As a result, this Form 4 is a voluntary report with respect to these purchases of the Issuer's common stock by the Foundation.

SEC source: 0001144204-19-028407 · tv522509_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 2,086,323

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.79 to $18.90, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares of the Issuer owned by the Schuler Family Foundation (the "Foundation"). Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's common stock. As a result, this Form 4 is a voluntary report with respect to these purchases of the Issuer's common stock by the Foundation.

SEC source: 0001144204-19-028143 · tv522428_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 2,053,723

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.92 to $19.20, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares of the Issuer owned by the Schuler Family Foundation (the "Foundation"). Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's common stock. As a result, this Form 4 is a voluntary report with respect to these purchases of the Issuer's common stock by the Foundation.

SEC source: 0001144204-19-027940 · tv522316_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 2,043,723

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.99 to $19.05, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares of the Issuer owned by the Schuler Family Foundation (the "Foundation"). Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's common stock. As a result, this Form 4 is a voluntary report with respect to these purchases of the Issuer's common stock by the Foundation.

SEC source: 0001144204-19-027697 · tv522141_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 2,024,423

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.94 to $19.14, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F5 · balance_after: Shares previously disclosed as being beneficially owned indirectly through the Schuler Grandchildren LLC have been omitted. The reporting person has ceased to be a manager of the Schuler Grandchildren LLC.

F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares of the Issuer owned by the Schuler Family Foundation (the "Foundation"). Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's common stock. As a result, this Form 4 is a voluntary report with respect to these purchases of the Issuer's common stock by the Foundation.

SEC source: 0000899243-20-017804 · doc4.xml · nonDerivative · entry 29

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 835,717

F1 · ownership.nature: The shares are held by the Schuler Family Foundation, for which the Reporting Person serves as President.

SEC source: 0001209191-19-030644 · doc4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,101,149

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Reflects release of restricted stock units that were previously reported on Form 4.

F2 · balance_after: In addition to the shares reported on this Form 4 as directly owned by the Reporting Person, 65,000 shares are held indirectly by the Reporting Person's spouse and 1,105,263 shares are held indirectly by the Schuler Family Foundation. The Reporting Person disclaims all beneficial ownership of the shares owned by his spouse and the Schuler Family Foundation, except to the extent of his pecuniary interest, if any.

SEC source: 0001209191-19-030644 · doc4.xml · derivative · entry 4

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,100

Underlying: Common Stock · 2,100 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock.

F6 · derivative.exercise_date: The restricted stock units vest on May 14, 2020.

F6 · derivative.expiration_date: The restricted stock units vest on May 14, 2020.

SEC source: 0001209191-19-030644 · doc4.xml · derivative · entry 3

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 262

Underlying: Common Stock · 262 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock.

F4 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule.

F6 · derivative.exercise_date: The restricted stock units vest on May 14, 2020.

F4 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule.

F6 · derivative.expiration_date: The restricted stock units vest on May 14, 2020.

SEC source: 0001209191-19-030644 · doc4.xml · derivative · entry 2

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 875

Underlying: Common Stock · 875 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock.

F4 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule.

F5 · derivative.exercise_date: The restricted stock units vest on the date of the grant, May 14, 2019.

F4 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule.

F5 · derivative.expiration_date: The restricted stock units vest on the date of the grant, May 14, 2019.

SEC source: 0000899243-20-017804 · doc4.xml · nonDerivative · entry 28

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 801,817

F1 · ownership.nature: The shares are held by the Schuler Family Foundation, for which the Reporting Person serves as President.